Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FHAD1 Activators

The chemical class labeled as FHAD1 Activators constitutes a set of compounds recognized for their capacity to modulate the activity of the FHAD1 gene. FHAD1, or Follicle-stimulating Hormone-associated D1, is a gene that encodes a protein whose precise function is still under investigation. While its exact role remains to be fully elucidated, FHAD1 has been associated with follicle-stimulating hormone (FSH) signaling pathways, suggesting a potential involvement in reproductive processes or gonadal function. Activators of FHAD1 are substances capable of enhancing the expression or function of this gene, thereby potentially influencing downstream cellular pathways and biological responses linked to FSH activity.

Identifying compounds as FHAD1 Activators typically involves rigorous screening processes to determine their ability to interact with the regulatory elements of the FHAD1 gene or modulate the activity of proteins involved in its expression. These activators may operate through various mechanisms, such as binding to specific DNA sequences within the gene promoter region, regulating the activity of transcription factors responsible for FHAD1 gene expression, or modulating post-translational modifications of the FHAD1 protein. Understanding the molecular interactions between these activators and the FHAD1 gene can provide valuable insights into reproductive biology and the regulation of gonadal function. Further exploration into FHAD1 Activators holds promise for uncovering novel pathways in reproductive physiology and potentially revealing new targets for research in reproductive health and fertility.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea induces DNA damage by inhibiting ribonucleotide reductase, potentially upregulating FHAD1 expression as part of the DNA damage response.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin causes DNA cross-linking and damage, which might trigger the expression of DNA repair proteins, including potentially FHAD1.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide induces DNA breaks by inhibiting topoisomerase II, potentially increasing FHAD1 expression as part of the cell's effort to repair DNA damage.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin intercalates into DNA and inhibits topoisomerase II, potentially inducing FHAD1 expression as part of the cellular response to DNA damage.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

By inhibiting topoisomerase I, Camptothecin induces DNA breaks, potentially upregulating FHAD1 expression as a component of the DNA damage response pathway.

Bleomycin

11056-06-7sc-507293
5 mg
$275.00
5
(0)

Bleomycin causes oxidative DNA damage, potentially inducing FHAD1 expression as part of the cellular repair mechanisms.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C cross-links DNA, potentially upregulating FHAD1 expression through activation of DNA damage response pathways.

Arsenic(III) oxide

1327-53-3sc-210837
sc-210837A
250 g
1 kg
$89.00
$228.00
(0)

Arsenic Trioxide induces oxidative stress and DNA damage, potentially leading to increased FHAD1 expression as part of the stress response mechanisms.

Cadmium chloride, anhydrous

10108-64-2sc-252533
sc-252533A
sc-252533B
10 g
50 g
500 g
$56.00
$183.00
$352.00
1
(1)

Cadmium Chloride is a toxic heavy metal that induces cellular stress and DNA damage, potentially increasing FHAD1 expression as part of the cellular defense mechanism.

Hydrogen Peroxide

7722-84-1sc-203336
sc-203336A
sc-203336B
100 ml
500 ml
3.8 L
$31.00
$61.00
$95.00
28
(1)

As a reactive oxygen species, Hydrogen Peroxide can induce oxidative stress and DNA damage, potentially upregulating FHAD1 expression in response to oxidative stress.